Demo Sign up Log In

Lineage Cell Therapeutics, Inc. Common Stock (LCTX)

Income Tax Expense

-$5.28M

TTM · Period ending: Jun 30, 2026 · USD

LCTX Income Tax Expense

Latest reported-$5.28Mperiod endingJun 30, 2026

Latest reported-$5.28Mperiod endingJun 30, 2026

LCTX TTM Income Tax ($700.00K → -$5.28M)

TTM income tax expense

High-resolution chart · PNG

LCTX income tax expense history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Lineage Cell Therapeutics, Inc. Common Stock Income Tax Expense — Trailing twelve months (TTM) (USD)
Period ending	Income Tax Expense (USD)
Jun 30, 2001	-62,563
Mar 31, 2001	-106,259
Dec 31, 2000	-165,254
Sep 30, 2000	-155,108
Jun 30, 2000	2,205,625
Mar 31, 2000	2,154,723
Dec 31, 1999	3,020,173
Sep 30, 1999	3,000,000
Jun 30, 1999	800,000
Mar 31, 1999	900,000
Sep 30, 1998	-100,000
Jun 30, 1998	-100,000
Mar 31, 1998	-400,000
Dec 31, 1997	100,000
Sep 30, 1997	400,000
Jun 30, 1997	500,000
Mar 31, 1997	-900,000
Dec 31, 1996	-700,000
Sep 30, 1996	-100,000
Jun 30, 1996	-100,000
Mar 31, 1996	1,400,000
Dec 31, 1995	800,000
Sep 30, 1995	200,000
Jun 30, 1995	200,000
Mar 31, 1995	100,000
Dec 31, 1994	100,000
Sep 30, 1994	100,000
Jun 30, 1994	300,000
Mar 31, 1994	400,000
Dec 31, 1993	500,000
Sep 30, 1993	700,000
Jun 30, 1993	500,000
Mar 31, 1993	800,000
Dec 31, 1992	700,000

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.